Search

everythinglearnresearchcommunity

for

Search:↓

The UK's EDS National Diagnostic Service found that early diagnosis, lifestyle advice, and regular check-ups are crucial for managing vascular Ehlers-Danlos syndrome. A combination of losartan and bisoprolol can reduce vascular events, improving survival and quality of life.

Faulty LEF1 activation causes faster skin cell differentiation in premature aging syndrome.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

A woman's hair loss improved with treatment after a COVID-19 infection.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Fibrodysplasia ossificans progressiva is a rare genetic disorder that causes extra bone growth and symptoms of premature aging.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

A patient with a rare disease had a unique genetic mutation linked to their symptoms.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

SER120 nasal spray effectively reduces nighttime urination and is safe for patients.

Mutations in the AR gene cause hair thinning and loss.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Eyelashes are important for looks and eye protection, and more people are treating sparse eyelashes; more research is needed to understand eyelash biology and improve treatments.

Hair loss linked to higher heart disease risk in both men and women.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

A document listed serious side effects from various drugs, including deaths and diseases, emphasizing the importance of being aware of drug side effects.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Balding men have higher heart disease risk.